Tools
Tools
Hung, MW, Zhang, ZJ, Li, S, Lei, B, Yuan, S, Cui, GZ, Hoi, PM, Chan, K and Lee, SMY (2012) From Omics to Drug Metabolism and High Content Screen of Natural Product in Zebrafish: A New Model for Discovery of Neuroactive Compound. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012. ISSN 1741-427X
|
Text
Evid-based Compl&AlternMed-Zebrafish review -.pdf - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview |
Abstract
The zebrafish (Danio rerio) has recently become a common model in the fields of genetics, environmental science, toxicology, and especially drug screening. Zebrafish has emerged as a biomedically relevant model for in vivo high content drug screening and the simultaneous determination of multiple efficacy parameters, including behaviour, selectivity, and toxicity in the content of the whole organism. A zebrafish behavioural assay has been demonstrated as a novel, rapid, and high-throughput approach to the discovery of neuroactive, psychoactive, and memory-modulating compounds. Recent studies found a functional similarity of drug metabolism systems in zebrafish and mammals, providing a clue with why some compounds are active in zebrafish in vivo but not in vitro, as well as providing grounds for the rationales supporting the use of a zebrafish screen to identify prodrugs. Here, we discuss the advantages of the zebrafish model for evaluating drug metabolism and the mode of pharmacological action with the emerging omics approaches. Why this model is suitable for identifying lead compounds from natural products for therapy of disorders with multifactorial etiopathogenesis and imbalance of angiogenesis, such as Parkinson's disease, epilepsy, cardiotoxicity, cerebral hemorrhage, dyslipidemia, and hyperlipidemia, is addressed.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 1104 Complementary and Alternative Medicine |
| Subjects: | Q Science > QH Natural history > QH301 Biology Q Science > QH Natural history > QH426 Genetics R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | HINDAWI LTD |
| Related URLs: | |
| Date Deposited: | 21 Feb 2022 12:54 |
| Last Modified: | 21 Feb 2022 12:54 |
| DOI or ID number: | 10.1155/2012/605303 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/16364 |
 |
View Item |